Latest Breaking News On - Abbvie roche - Page 1 : comparemela.com

Among the 10 patients in the retrospective analysis, the median overall survival after allogeneic hematopoietic stem cell transplantation (allo-HSCT) for relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) was 21 months.

Abbvie rochePharmacyclics janssenFirst affiliated hospital of soochow universityExperimental hematologyFirst affiliated hospitalSoochow universityRr dlbclAllo hsct